Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Periorbital necrobiotic xanthogranuloma resolved with three years of systemic lenalidomide treatment.
Am J Ophthalmol Case Rep
March 2025
Ophthalmic Surgeons and Consultants of Ohio, Columbus, OH, USA.
Purpose: To describe a case report of the successful management of necrobiotic xanthogranuloma (NXG), a rare periorbital disease.
Observations: A 61-year-old patient presented with bilateral upper and lower lid lesions which were initially misdiagnosed as xanthelasmas and later confirmed to be NXG. Further investigation also uncovered a diagnosis of multiple myeloma.
A case of ulcerated nodules in association with a monoclonal gammopathy.
JAAD Case Rep
December 2024
Department of Dermatology, Kings College Hospital, London, UK.
Foamy Cell Angiosarcoma Resembling a Xanthomatous Histiocytic Infiltrate Without Evidence of Vascular Malignancy.
J Cutan Pathol
December 2024
Department of Medicine, Division of Dermatology, St. Louis School of Medicine, Washington University, St. Louis, Missouri, USA.
Angiosarcoma is a rare and aggressive malignancy of endothelial cells with multiple subtypes. Foamy cell angiosarcoma is a rare variant in which endothelial cells demonstrate "foamy" cytoplasmic change. We present the case of a 59-year-old male who presented with progressive erythema and swelling of the midface and bilateral eyelids.
View Article and Find Full Text PDFResponse to: "Potential sitosterolemia in necrobiotic xanthogranuloma: Comment on Extensive yellowish masses in bilateral orbit and neck" by Chen et al.
J Dermatol
November 2024
Department of Rheumatology and Immunology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, Jiangsu, China.
Potential sitosterolemia in necrobiotic xanthogranuloma: Comment on "Extensive yellowish masses in bilateral orbit and neck".
J Dermatol
October 2024
Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!